This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention CenterBoston, USA

Sung Hyun Choi, Ph.D.
Director & Head of R&D Center at Affyxell Therapeutics Co., Ltd.


Dr. Sung Hyun Choi currently serves as the Director of the R&D Center at AffyXell Therapeutics Co., Ltd., where he focuses on advancing cell and gene therapy technologies to target immune diseases. Since 2020, he has been dedicated to developing next-generation therapies for overcoming immune disorders at AffyXell Therapeutics.

With a comprehensive background in both academia and industry, Dr. Choi earned his doctoral degree in Molecular Cell Biology from the School of Medicine at The Catholic University of Korea. Following this, he pursued post-doctoral research at the Department of Physiology, Pusan National University School of Medicine.

Dr. Choi then transitioned to Daewoong Pharmaceuticals Co., Ltd., contributing to research in DW-MSC platform technology development.His professional journey reflects a commitment to pushing the boundaries of cellular therapeutics, leveraging his expertise to drive innovation in the field.

Agenda Sessions

  • Revolutionizing Substantive Off-the-shelf MSC Therapeutics for Restoring Immune Balance